ConductScience.org, home

Paper19856484

Pravastatin use and cancer risk: a meta-analysis of individual patient data from long-term prospective controlled trials in Japan.

Matsushita Y and 7 others. Pharmacoepidemiol Drug Saf, 2010. Cited by 39 papers, by iCite.

Cite this record

ConductScience Library. Pravastatin use and cancer risk: a meta-analysis of individual patient data from long-term prospective controlled trials in Japan. Papers, record 19856484. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/19856484

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Pravastatin use and cancer risk: a meta-analysis of individual patient data from long-term prospective controlled trials in Japan.
PubMed
Journal
Pharmacoepidemiol Drug Saf
PubMed
Year
2010
PubMed
Publication types
Journal Article, Meta-Analysis
PubMed
Citations, by iCite
39
iCite
Relative citation ratio, by iCite
1.05
iCite
Revised in PubMed
2013-11-21
PubMed

Authors8

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Matsushita YYasuyuki
2Sugihara MMasahiro
3Kaburagi JJunpei
4Ozawa MMasumi
5Iwashita MMikio
6Yoshida SSanae
7Saito HHanako
8Hattori YYoko

Source PubMed

Download CSV of authors

Topics10

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Anticholesteremic AgentsMajor topic
NeoplasmsMajor topic
PravastatinMajor topic
Controlled Clinical Trials as Topic
Female
Humans
Japan
Male
Middle Aged
Risk Factors

Source PubMed

Download CSV of topics

Comments and corrections1

PubMed's comments and corrections, NLM's own indexing: retractions first, then expressions of concern, errata and updates, and comments last.

KindPMIDTitleIn Papers
Comment in20101642Commentary on pravastatin and cancer: need for individual patient data meta-analyses.https://conductscience.org/library/papers/20101642

Source PubMed

Download CSV of comments and corrections

Cited by28

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 39 citations.

PMIDTitleJournalYearIn PapersSource
38284728Statin Use and Hepatocellular Carcinoma Risk: A Comprehensive Meta-Analysis and Systematic Review.Recent Pat Anticancer Drug Discov2025https://conductscience.org/library/papers/38284728PubMed
37894467Don't Judge a Book by Its Cover: The Role of Statins in Liver Cancer.Cancers (Basel)2023https://conductscience.org/library/papers/37894467PubMed
36672322Exposure to Commonly Used Drugs and the Risk of Gastric Cancer: An Umbrella Review of Meta-Analyses.Cancers (Basel)2023https://conductscience.org/library/papers/36672322PubMed
36498753Statins and the Risk of Gastric Cancer: A Systematic Review and Meta-Analysis.J Clin Med2022https://conductscience.org/library/papers/36498753PubMed
36229904Statin Intake and Gastric Cancer Risk: An Updated Subgroup Meta-analysis Considering Immortal Time Bias.J Prev Med Public Health2022https://conductscience.org/library/papers/36229904PubMed
35989795Statin Use Reduces the Risk of Hepatocellular Carcinoma: An Updated Meta-Analysis and Systematic Review.Cureus2022https://conductscience.org/library/papers/35989795PubMed
35356132A Meta-Analysis of Statin Use and Risk of Hepatocellular Carcinoma.Can J Gastroenterol Hepatol2022https://conductscience.org/library/papers/35356132PubMed
35154535The role of statins in lung cancer.Arch Med Sci2022https://conductscience.org/library/papers/35154535PubMed
34970858Aspirin, metformin, and statin use on the risk of gastric cancer: A nationwide population-based cohort study in Korea with systematic review and meta-analysis.Cancer Med2022https://conductscience.org/library/papers/34970858PubMed
33654016Statins for treatment of chronic liver disease.Curr Opin Gastroenterol2021https://conductscience.org/library/papers/33654016PubMed
32260179Statin Use Decreases the Incidence of Hepatocellular Carcinoma: An Updated Meta-Analysis.Cancers (Basel)2020https://conductscience.org/library/papers/32260179PubMed
32183029Statin Use and the Risk of Hepatocellular Carcinoma: A Meta-Analysis of Observational Studies.Cancers (Basel)2020https://conductscience.org/library/papers/32183029PubMed
31513091Statin therapy: does sex matter?Menopause2019https://conductscience.org/library/papers/31513091PubMed
31426090Lipophilic Statins and Risk for Hepatocellular Carcinoma and Death in Patients With Chronic Viral Hepatitis: Results From a Nationwide Swedish Population.Ann Intern Med2019https://conductscience.org/library/papers/31426090PubMed
31041062Statins and metformin for chemoprevention of hepatocellular carcinoma.Clin Liver Dis (Hoboken)2016https://conductscience.org/library/papers/31041062PubMed
29770171Risk of gastric cancer development after eradication of Helicobacter pylori.World J Gastrointest Oncol2018https://conductscience.org/library/papers/29770171PubMed
27468210Pleiotropic effects of statins in the diseases of the liver.World J Gastroenterol2016https://conductscience.org/library/papers/27468210PubMed
27198922Meta-analysis of studies using statins as a reducer for primary liver cancer risk.Sci Rep2016https://conductscience.org/library/papers/27198922PubMed
25904829Effects of statins on the risk of hepatocellular carcinoma.Gastroenterol Hepatol (N Y)2014https://conductscience.org/library/papers/25904829PubMed
25722350Statin use and risk of primary liver cancer in the Clinical Practice Research Datalink.J Natl Cancer Inst2015https://conductscience.org/library/papers/25722350PubMed

See all 28 cited byDownload CSV of cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • References
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/19856484

GET https://conductscience.org/api/papers/v1/19856484/cited_by?page=2